Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on January 7, 2026

Jan. 7, 2026

LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates

GlobeNewswire

Jan. 7, 2026

MESA LABS DECLARES QUARTERLY DIVIDEND

GlobeNewswire

Jan. 7, 2026

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

GlobeNewswire

Jan. 7, 2026

Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio

GlobeNewswire

Jan. 7, 2026

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

GlobeNewswire

Jan. 7, 2026

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 7, 2026

Abivax Provides 2026 Corporate Outlook

GlobeNewswire

Jan. 7, 2026

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis

GlobeNewswire

Jan. 7, 2026

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 7, 2026

BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

GlobeNewswire

Jan. 7, 2026

Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 7, 2026

Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors

GlobeNewswire

Jan. 7, 2026

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

Jan. 7, 2026

Genelux Corporation Announces Proposed Public Offering of Common Stock

GlobeNewswire

Jan. 7, 2026

Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

Jan. 7, 2026

Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Jan. 7, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

GlobeNewswire

Jan. 7, 2026

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

GlobeNewswire

Jan. 7, 2026

Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

GlobeNewswire

Jan. 7, 2026

HyperCharge Health issues new statement calling for increased attention on Minnesota's Lyme Disease Crisis

GlobeNewswire